29.04.24 | Vollzeit | Krailling | Formycon AGFormycon is an international leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. With an experienced team comprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from
Später ansehen29.04.24 | Vollzeit | Germering | Formycon AGdrug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon is making
Später ansehen29.04.24 | Vollzeit | Augsburg | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen29.04.24 | Vollzeit | Augsburg | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen29.04.24 | Vollzeit | Unterschleißheim | Formycon AGdrug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon is making
Später ansehen29.04.24 | Vollzeit | Krailling | Formycon AGdrug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon is making
Später ansehen29.04.24 | Vollzeit | Augsburg | Formycon AGThe company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology
Später ansehen22.04.24 | Vollzeit | Krailling | proteros biostructures GmbHProteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros' work is built on scientific excellence and supports its clients to reach the right results
Später ansehen22.04.24 | Vollzeit | Krailling | proteros biostructures GmbHProteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros' work is built on scientific excellence and supports its clients to reach the right results
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Drug in Starnberg Landkreis kostenlos abonnieren.